News & Analysis as of

Congressional Committees Information Reports Trump Administration

Latham & Watkins LLP

Healthcare Life Sciences Drug Pricing Digest - May 2025

Latham & Watkins LLP on

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....more

WilmerHale

Weekly COVID-19 Oversight & Enforcement Report - February 2021 #2

WilmerHale on

The Select Subcommittee on the Coronavirus Crisis sent letters to the White House and the Department of Health and Human Services summarizing initial results of the panel’s investigation into the previous administration’s...more

Holland & Knight LLP

President Trump's Budget Seeks FDA Resources for CBD Enforcement | Insights

Holland & Knight LLP on

In the midst of expanded development and marketing of products containing cannabis and cannabis-derived compounds, President Donald Trump's FY 2021 proposed budget includes an additional $5 million for the U.S. Food and Drug...more

Seyfarth Shaw LLP

Federal Legislators Tell NLRB GC Griffin to Rescind His Education Report or Step Aside

Seyfarth Shaw LLP on

Seyfarth Synopsis: Congressional Committee Head Virginia Foxx (R-NC) and Subcommittee Chair Tim Walberg (R-MI) ask NLRB General Counsel Griffin to either immediately rescind his January 31 report regarding the purported...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide